| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.4 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.024 | 0.4 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |